Cardinal Health

Pharmaceuticals
CAH
$ 56 0.95
Share price
$ 15 bn
Market Cap
$ 19 bn
Enterprise Value

Carbon footprint

24 Ton
GHG emissions per $ 1 mln investment
0.85x the weighted average for S&P 500
FY2020
How is this calculated?
-15%
YOY change in GHG emissions
Stronger than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-4.1%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Cardinal Health aims to reduce Scope 1 + 2 by 50% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
Cardinal Health's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Cardinal Health's GHG emissions (location-based) (Kt of CO2e)
Cardinal Health's Carbon intensity (Tons per 1 USDm)

Cardinal Health's carbon footprint

Cardinal Health reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2020 at 443 Kt (-76 /-14.6% y-o-y). Also positively, carbon intensity plunged to 2.9 t (-0.7 /-19.4% y-o-y).

Cardinal Health's Scope 3 emissions plunged to 11 Kt (-5 /-31.2% y-o-y). The decline accelerated compared to the CAGR of -21.8% since 2Q'18.

The company is committed to reducing Scope 1 + 2 by 50% by 2030 from a base year 2019, which translates into the estimated reduction of -18 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...